CDRI Competitors

Glenmark Pharmaceuticals Limited is a research-led, global organization committed to enriching lives. Innovation is deeply embedded in Glenmark’s culture; it is how we differentiate ourselves in our key markets and create greater value for our stakeholders. In our journey of innovation over the past four and a half decades, we have evolved from a generics company to a global organization offering specialty and branded products. Glenmark’s core values of Achievement, Respect, and Knowledge impart a sense of organizational unity that drives our growth. We have established a robust global branded generics, specialty, and OTC business; with a significant presence in the therapy areas of dermatology, respiratory, and oncology. Our ten state-of-the-art manufacturing facilities spread across four continents with operations in over 80 countries help us impact millions of patients across the globe. We recently consolidated our innovation efforts in small molecules and biologics research with the formation of ‘Ichnos Glenmark Innovation’ (IGI). This alliance is aimed at leveraging the capabilities of Glenmark and its subsidiary, Ichnos Sciences, to accelerate innovation in cancer treatment. To know more about IGI, check out: https://iginnovate.com/ Sustainability is an integral aspect of all our operations and we are focused on achieving our Environment, Social and Governance (ESG) goals. Our responsibility also extends to our communities, and over the years, our CSR efforts have touched the lives of over 3 million people.

The Indian Institute of Science (IISc) was founded in 1909 as a result of the joint efforts of Jamsetji Nusserwanji Tata, the Government of India, and the Maharaja of Mysore. In 1886, Jamsetji Tata conceived of a university of science that would work for the benefit of India, and in 1898 created an endowment for establishing such an institution. The Government of India then took up the effort, and, in consultation with scientists in England and in India, decided to locate the Institute in Bengaluru, where the Maharaja of Mysore, Shri Krishnaraja Wodeyar IV, donated 372 acres of land. The Institute was formally vested in 1909, the foundation stone was laid in 1911, and the first batch of students started their studies in the same year. Over the last century, IISc has become the premier institute for advanced scientific and technological research and education in India. Beginning with 2 departments and 21 students in 1911, today IISc has 39 departments, units, or centres, 3500 students, and about 500 academic and scientific staff, supported by 600 administrative personnel. About 2200 students are in various PhD programs, almost 900 are enrolled for various Masters degrees, whereas about 400 are registered in the newly established, research oriented, four-year Bachelor of Science (Research) programme. In recent years, the Institute has vigorously promoted interdisciplinary research. New centres such as the CiSTUP, the Robert Bosch Centre for Cyber Physical Systems and a new Centre for Brain Research (funded by a large private endowment) are expected to conduct translational research in their respective areas, in order to better connect with industry and society. With the recent construction of modern buildings, acquisition of new research facilities, and induction of a large number of new faculty members, the Institute can look forward to an era of high productivity, increasing impact, and rising prominence in the world.

- Offices in over 30 countries - Brand presence in over 100 global markets - Team of over 10,000 people from 21 diverse nationalities Piramal Group is a global business conglomerate with diverse interests in Pharma, Financial Services, and Real Estate. The Group has offices in over 30 countries and a global brand presence in more than 100 markets. Led by Mr Ajay Piramal, the Chairman, Piramal Group is a torchbearer of trusteeship and responsible business ethos. Based on the philosophy of ‘Doing Well and Doing Good’, the Group continues to create long-term value for its stakeholders and the community at large. In the three decades of its existence, Piramal Group has pursued a twin strategy of both organic and inorganic growth. Driven by its core values, Piramal Group steadfastly pursues inclusive growth, while adhering to ethical and values-driven practices. Piramal Foundation, the philanthropic arm of the Piramal Group develops innovative solutions to resolve issues that are critical roadblocks towards unlocking India’s economic potential. Its sustainable development programmes in healthcare & nutrition, education and safe drinking water across 25 Indian states, largely in partnership with the central and state governments have impacted over 100 Million lives till date. Each social initiative nurtured by the Piramal Foundation addresses one of the three focus areas : Piramal Swasthya: Primary Healthcare and Nutrition Piramal School of Leadership: Education Leadership and Women & Youth Empowerment Piramal Sarvajal: Access to Safe Drinking Water